Nektar Therapeutics (LON:0UNL)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $24.12M USD in the quarter ending September 30, 2024, a decrease of -0.08%. This brings the company's revenue in the last twelve months to $93.14M, up 5.53% year-over-year. In the year 2023, Nektar Therapeutics had annual revenue of $90.12M, down -2.10%.

• Revenue (ttm): $93.14M
• Revenue Growth: +5.53%
• P/S Ratio: n/a
• Revenue / Employee: $679.83K
• Employees: 137
• Market Cap: 136.02M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%
Dec 31, 2019	114.62M	-1.08B	-90.40%